Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
582 | 3285 | 36.7 | 81% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
6 | 4 | GASTROENTEROLOGY & HEPATOLOGY//ONCOLOGY//SURGERY | 1371034 |
261 | 3 | HELICOBACTER PYLORI//GASTROENTEROLOGY & HEPATOLOGY//HELICOBACTER | 44585 |
196 | 2 | HELICOBACTER PYLORI//HELICOBACTER//GASTRITIS | 21432 |
582 | 1 | HELICOBACTER PYLORI//CLARITHROMYCIN//TRIPLE THERAPY | 3285 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | HELICOBACTER PYLORI | authKW | 1504141 | 41% | 12% | 1338 |
2 | CLARITHROMYCIN | authKW | 792644 | 10% | 27% | 313 |
3 | TRIPLE THERAPY | authKW | 574529 | 4% | 43% | 145 |
4 | ERADICATION | authKW | 520618 | 9% | 18% | 305 |
5 | QUADRUPLE THERAPY | authKW | 516127 | 2% | 91% | 61 |
6 | CLARITHROMYCIN RESISTANCE | authKW | 510334 | 2% | 89% | 62 |
7 | HELICOBACTER | journal | 500525 | 8% | 20% | 264 |
8 | METRONIDAZOLE | authKW | 301208 | 7% | 14% | 225 |
9 | SEQUENTIAL THERAPY | authKW | 268090 | 2% | 35% | 82 |
10 | RANITIDINE BISMUTH CITRATE | authKW | 258726 | 1% | 80% | 35 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Gastroenterology & Hepatology | 131578 | 60% | 1% | 1973 |
2 | Microbiology | 10127 | 24% | 0% | 787 |
3 | Pharmacology & Pharmacy | 6123 | 27% | 0% | 876 |
4 | Infectious Diseases | 1834 | 8% | 0% | 254 |
5 | Medicine, General & Internal | 1422 | 11% | 0% | 364 |
6 | Primary Health Care | 29 | 0% | 0% | 13 |
7 | Medicine, Research & Experimental | 20 | 2% | 0% | 72 |
8 | Tropical Medicine | 6 | 0% | 0% | 14 |
9 | Health Policy & Services | 2 | 0% | 0% | 13 |
10 | Chemistry, Medicinal | 1 | 1% | 0% | 32 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | GASTROENTEROL | 80765 | 25% | 1% | 815 |
2 | REFERENCE HELICOBACTER PYLORI | 49560 | 0% | 67% | 8 |
3 | URGENT ENDOSCOPY UNIT | 46468 | 0% | 100% | 5 |
4 | UNITAT MALALTIES DIGEST | 37629 | 0% | 45% | 9 |
5 | PESCARA CIV HOSP | 37174 | 0% | 100% | 4 |
6 | GASTROENTEROL UNIT | 23121 | 3% | 3% | 99 |
7 | HELICOBACTER REFERENCE UNIT | 22865 | 0% | 31% | 8 |
8 | DIGEST PHYSIOPATHOL UNIT | 21239 | 0% | 57% | 4 |
9 | INVEST SANITARIA PRINCESA IP | 18671 | 1% | 11% | 18 |
10 | BIOESTADIST CLIN | 18587 | 0% | 100% | 2 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | HELICOBACTER | 500525 | 8% | 20% | 264 |
2 | ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 253296 | 13% | 7% | 418 |
3 | EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY | 26546 | 4% | 2% | 126 |
4 | AMERICAN JOURNAL OF GASTROENTEROLOGY | 15731 | 4% | 1% | 140 |
5 | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 10795 | 3% | 1% | 88 |
6 | SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY | 9988 | 3% | 1% | 103 |
7 | WORLD JOURNAL OF GASTROENTEROLOGY | 8699 | 4% | 1% | 125 |
8 | DIGESTIVE AND LIVER DISEASE | 7367 | 1% | 2% | 46 |
9 | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 6359 | 4% | 1% | 129 |
10 | JOURNAL OF CLINICAL GASTROENTEROLOGY | 6039 | 2% | 1% | 62 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | HELICOBACTER PYLORI | 1504141 | 41% | 12% | 1338 | Search HELICOBACTER+PYLORI | Search HELICOBACTER+PYLORI |
2 | CLARITHROMYCIN | 792644 | 10% | 27% | 313 | Search CLARITHROMYCIN | Search CLARITHROMYCIN |
3 | TRIPLE THERAPY | 574529 | 4% | 43% | 145 | Search TRIPLE+THERAPY | Search TRIPLE+THERAPY |
4 | ERADICATION | 520618 | 9% | 18% | 305 | Search ERADICATION | Search ERADICATION |
5 | QUADRUPLE THERAPY | 516127 | 2% | 91% | 61 | Search QUADRUPLE+THERAPY | Search QUADRUPLE+THERAPY |
6 | CLARITHROMYCIN RESISTANCE | 510334 | 2% | 89% | 62 | Search CLARITHROMYCIN+RESISTANCE | Search CLARITHROMYCIN+RESISTANCE |
7 | METRONIDAZOLE | 301208 | 7% | 14% | 225 | Search METRONIDAZOLE | Search METRONIDAZOLE |
8 | SEQUENTIAL THERAPY | 268090 | 2% | 35% | 82 | Search SEQUENTIAL+THERAPY | Search SEQUENTIAL+THERAPY |
9 | RANITIDINE BISMUTH CITRATE | 258726 | 1% | 80% | 35 | Search RANITIDINE+BISMUTH+CITRATE | Search RANITIDINE+BISMUTH+CITRATE |
10 | ERADICATION RATE | 249831 | 1% | 79% | 34 | Search ERADICATION+RATE | Search ERADICATION+RATE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | THUNG, I , ARAMIN, H , VAVINSKAYA, V , GUPTA, S , PARK, JY , CROWE, SE , VALASEK, MA , (2016) REVIEW ARTICLE: THE GLOBAL EMERGENCE OF HELICOBACTER PYLORI ANTIBIOTIC RESISTANCE.ALIMENTARY PHARMACOLOGY & THERAPEUTICS. VOL. 43. ISSUE 4. P. 514 -533 | 131 | 69% | 12 |
2 | MEGRAUD, F , (2004) H PYLORI ANTIBIOTIC RESISTANCE: PREVALENCE, IMPORTANCE, AND ADVANCES IN TESTING.GUT. VOL. 53. ISSUE 9. P. 1374-1384 | 128 | 98% | 471 |
3 | GISBERT, JP , (2008) "RESCUE" REGIMENS AFTER HELICOBACTER PYLORI TREATMENT FAILURE.WORLD JOURNAL OF GASTROENTEROLOGY. VOL. 14. ISSUE 35. P. 5385-5402 | 146 | 95% | 50 |
4 | GISBERT, JP , MOLINA-INFANTE, J , AMADOR, J , BERMEJO, F , BUJANDA, L , CALVET, X , CASTRO-FERNANDEZ, M , CUADRADO-LAVIN, A , ELIZALDE, JI , GENE, E , ET AL (2016) IV SPANISH CONSENSUS CONFERENCE ON HELICOBACTER PYLORI INFECTION TREATMENT.GASTROENTEROLOGIA Y HEPATOLOGIA. VOL. 39. ISSUE 10. P. 697 -721 | 145 | 87% | 0 |
5 | GISBERT, JP , (2012) RESCUE THERAPY FOR HELICOBACTER PYLORI INFECTION 2012.GASTROENTEROLOGY RESEARCH AND PRACTICE. VOL. . ISSUE . P. - | 129 | 98% | 17 |
6 | GRAHAM, DY , FISCHBACH, L , (2010) HELICOBACTER PYLORI TREATMENT IN THE ERA OF INCREASING ANTIBIOTIC RESISTANCE.GUT. VOL. 59. ISSUE 8. P. 1143 -1153 | 104 | 78% | 305 |
7 | FALLONE, CA , CHIBA, N , VAN ZANTEN, SV , FISCHBACH, L , GISBERT, JP , HUNT, RH , JONES, NL , RENDER, C , LEONTIADIS, GI , MOAYYEDI, P , ET AL (2016) THE TORONTO CONSENSUS FOR THE TREATMENT OF HELICOBACTER PYLORI INFECTION IN ADULTS.GASTROENTEROLOGY. VOL. 151. ISSUE 1. P. 51 -+ | 84 | 79% | 11 |
8 | PAPASTERGIOU, V , GEORGOPOULOS, SD , KARATAPANIS, S , (2014) TREATMENT OF HELICOBACTER PYLORI INFECTION: MEETING THE CHALLENGE OF ANTIMICROBIAL RESISTANCE.WORLD JOURNAL OF GASTROENTEROLOGY. VOL. 20. ISSUE 29. P. 9898 -9911 | 114 | 83% | 20 |
9 | FISCHBACH, L , EVANS, EL , (2007) META-ANALYSIS: THE EFFECT OF ANTIBIOTIC RESISTANCE STATUS ON THE EFFICACY OF TRIPLE AND QUADRUPLE FIRST-LINE THERAPIES FOR HELICOBACTER PYLORI.ALIMENTARY PHARMACOLOGY & THERAPEUTICS. VOL. 26. ISSUE 3. P. 343-357 | 104 | 94% | 172 |
10 | IERARDI, E , GIORGIO, F , LOSURDO, G , DI LEO, A , PRINCIPI, M , (2013) HOW ANTIBIOTIC RESISTANCES COULD CHANGE HELICOBACTER PYLORI TREATMENT: A MATTER OF GEOGRAPHY?.WORLD JOURNAL OF GASTROENTEROLOGY. VOL. 19. ISSUE 45. P. 8168-8180 | 114 | 81% | 25 |
Classes with closest relation at Level 1 |